Zoetis Inc. (NYSE: ZTS) today announced that the European Commission has granted the company a license for Stronghold® Plus (selamectin/sarolaner) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE